Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • coonya
    Junior Member
    • May 2008
    • 3

    SOLiD v3 vs Solexa

    Hi.

    Are there anybody who use SOLiD v3 and solexa sequencers?

    I just want to know that SOliD v3 system have a problems and what's the disadvantage of SoliD compare with Solexa.

    Thank you.
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #2
    SOLiD v.3 is rather new technology. It is just being rolled out (we may ours by the end of the month). I doubt if you will much feedback on how SOLiD v.3 works much less a comparison of Solexa versus SOLiD v.3.

    My gut level feeling -- not having either platform -- is that Solexa is easier to set up and run on the laboratory side. SOLiD v.3 with 50 base paired reads will be very nice. Lots of data that can, maybe, be de-novo aligned.

    Comment

    • Chipper
      Senior Member
      • Mar 2008
      • 323

      #3
      Any specific concerns? SOLiD v3 seems to be much improved in handling (labwise) compared to v2, not sure how it compares to Illumina. Sample preps are similar, not yet automated on either system. SOLiD will give more reads per run (2 slides, currently around 100 000 000 aligned reads per slide seems normal) but Illumina can do longer reads (> 100 bases reported).

      Comment

      • NextGenSeq
        Senior Member
        • Apr 2009
        • 482

        #4
        SOLiD v3 was released in February 2009 thus every comparison study to date was done using older versions.

        The Genome Analyzer is up to version IIx and was also upgraded this year.

        Both Illumina and ABI are claiming that they will get over 90Gb of sequence data by the end of the year.

        Comment

        • westerman
          Rick Westerman
          • Jun 2008
          • 1104

          #5
          Originally posted by Chipper View Post
          Any specific concerns? SOLiD v3 seems to be much improved in handling (labwise) compared to v2 ...
          No specific concerns since we have yet to do the lab work for an actual v.3 run. v.3 is suppose to be more simple ... but there is a long way between "suppose to" and "really acts like".

          I hope to be able to report some limited real-life experience in a month or so.

          Comment

          • jOn
            Member
            • Oct 2008
            • 19

            #6
            Originally posted by westerman View Post
            No specific concerns since we have yet to do the lab work for an actual v.3 run. v.3 is suppose to be more simple ... but there is a long way between "suppose to" and "really acts like".

            I hope to be able to report some limited real-life experience in a month or so.

            Hi westerman, I was just wondering if you'd had any experiences that you could feed back relating to this link. We currently have a 454 and are debating on what platform to invest in next. Any feedback you could offer would be great.

            Comment

            • westerman
              Rick Westerman
              • Jun 2008
              • 1104

              #7
              Originally posted by jOn View Post
              Hi westerman, I was just wondering if you'd had any experiences that you could feed back relating to this link. We currently have a 454 and are debating on what platform to invest in next. Any feedback you could offer would be great.
              The lab people do like the v.3 chemistry more than v.2. On the informatics side having 300 million 50 base pair mate reads is really nice to have. One could envision being close to de-novo assembly. I am not that enthused about the Corona lite software that ABI/LifeTech provides but it does do a lot -- SNP calling, Indels, transcriptomes, etc. Additionally there have sprung up other programs that deal with the SOLiD's color-space data format; these programs may provide easier or better results than Corona Lite. Support from ABI is generally good.

              As for which platform would be better -- Solexa or SOLiD -- I can not really comment on since we do not have a Solexa. I recall reading that there are more Solexas out in the field than SOLiD machines but that could just be due to a first-arrival-on-the-scene scenario.

              Comment

              • jOn
                Member
                • Oct 2008
                • 19

                #8
                Many thanks - that member# of yours is pretty Rock n Roll too.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM
                • GATTACAT
                  Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
                  by GATTACAT
                  Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
                  07-01-2026, 11:43 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                20 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                30 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-08-2026, 10:08 AM
                0 responses
                18 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-07-2026, 11:05 AM
                0 responses
                34 views
                0 reactions
                Last Post SEQadmin2  
                Working...